Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Inovio Pharma (INO)

Inovio Pharma (INO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,712,306
  • Shares Outstanding, K 210,357
  • Annual Sales, $ 7,410 K
  • Annual Income, $ -166,410 K
  • 60-Month Beta 0.62
  • Price/Sales 219.98
  • Price/Cash Flow N/A
  • Price/Book 3.51
Trade INO with:

Options Overview

Details
  • Implied Volatility 84.64%
  • Historical Volatility 42.38%
  • IV Percentile 8%
  • IV Rank 13.19%
  • IV High 229.68% on 01/27/21
  • IV Low 62.59% on 08/04/21
  • Put/Call Vol Ratio 0.30
  • Today's Volume 18,558
  • Volume Avg (30-Day) 9,684
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 127,875
  • Open Int (30-Day) 118,511

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.33
  • Number of Estimates 6
  • High Estimate -0.25
  • Low Estimate -0.42
  • Prior Year -0.22
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.43 +9.56%
on 09/15/21
9.59 -15.12%
on 08/26/21
-0.31 (-3.67%)
since 08/17/21
3-Month
7.43 +9.56%
on 09/15/21
9.96 -18.27%
on 08/12/21
-0.68 (-7.71%)
since 06/17/21
52-Week
5.81 +40.10%
on 05/11/21
19.00 -57.16%
on 02/02/21
-7.53 (-48.05%)
since 09/17/20

Most Recent Stories

More News
October 29th Options Now Available For Inovio Pharmaceuticals

Investors in Inovio Pharmaceuticals Inc. saw new options become available today, for the October 29th expiration.

INO : 8.14 (+5.03%)
Moderna vs. Inovio Pharmaceuticals: Which Coronavirus Vaccine Stock is a Better Investment?

Because the resurgence of COVID-19 cases is increasing the demand for vaccines, shares of vaccine-producing companies Moderna (MRNA) and Inovio Pharmaceuticals (INO) should benefit. But which of these...

MRNA : 430.05 (-2.41%)
INO : 8.14 (+5.03%)
INOVIO to Present at Upcoming Investor Conferences in September

INO : 8.14 (+5.03%)
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated...

INO : 8.14 (+5.03%)
Zika Virus Vaccine Market Comprehensive study explores Huge Growth in Future

The latest analysis released by HTF MI on “Worldwide Zika Virus Vaccine Market Outlook 2020 Survey results” sheds light on how investment and competitive landscape is impacted due to significant changes...

GILD : 71.61 (+0.39%)
IMV.TO : 2.23 (+0.45%)
INO : 8.14 (+5.03%)
NLNK : 8.0100 (-12.75%)
Inovio Pharmaceuticals (INO) Reports Q2 Loss, Misses Revenue Estimates

Inovio (INO) delivered earnings and revenue surprises of -56.00% and -1.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

INO : 8.14 (+5.03%)
Inovio: Q2 Earnings Snapshot

PLYMOUTH MEETING, Pa. (AP) _ Inovio Pharmaceuticals Inc. (INO) on Monday reported a loss of $82.1 million in its second quarter.

INO : 8.14 (+5.03%)
INOVIO Reports Second Quarter 2021 Financial Results

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated...

INO : 8.14 (+5.03%)
INOVIO and Advaccine Receive Regulatory Allowance for Two Heterologous Prime-Boost Clinical Trials in China Using INO-4800, INOVIO's COVID-19 DNA Vaccine Candidate

and SUZHOU, , /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer,...

INO : 8.14 (+5.03%)
INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease

/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases,...

INO : 8.14 (+5.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

3rd Resistance Point 8.77
2nd Resistance Point 8.46
1st Resistance Point 8.30
Last Price 8.14
1st Support Level 7.83
2nd Support Level 7.52
3rd Support Level 7.36

See More

52-Week High 19.00
Fibonacci 61.8% 13.96
Fibonacci 50% 12.40
Fibonacci 38.2% 10.85
Last Price 8.14
52-Week Low 5.81

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar